Anika Therapeutics Inc. (ANIK)

Nasdaq: ANIK · Surgical & Medical Instruments & Apparatus · Bedford, MA · filing with the SEC since 1996

Grade5.5

◀ Past 5.7● Present 5.4▶ Future 5.6

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 3, 2026	Mar 17, 2025	Mar 15, 2024	Mar 16, 2023	Mar 11, 2022	Mar 5, 2021	Mar 6, 2020	Feb 27, 2019	Feb 27, 2018	Feb 24, 2017
Revenue	112,819,000	119,907,000	120,792,000^r	113,827,000^r	147,794,000	130,457,000	114,610,000	105,555,000	113,420,000	103,379,000
Cost of revenue	49,012,000	43,909,000	38,260,000^r	40,607,000^r	64,851,000	61,431,000	28,747,000	31,280,000	27,364,000	24,027,000
Gross profit	63,807,000	75,998,000	82,532,000^r	73,220,000^r	82,943,000	69,026,000	85,863,000	74,275,000	·	·
Research and development	25,770,000	25,544,000	21,763,000^r	18,321,000^r	27,327,000	23,431,000	16,665,000	18,190,000	18,787,000	10,732,000
Selling, general and administrative	49,088,000	55,555,000	59,925,000^r	51,229,000^r	74,096,000	60,063,000	34,950,000	34,336,000	21,540,000	18,013,000
Total costs and expenses	74,858,000	81,099,000	81,688,000^r	69,550,000^r	80,328,000	97,348,000	51,615,000^r	52,526,000^r	67,691,000	52,772,000
Operating income	-11,051,000	-5,101,000	844,000^r	3,670,000^r	2,615,000	-28,322,000	34,248,000	21,749,000	45,729,000	50,607,000
Interest income (expense), net	1,744,000	2,337,000	2,312,000	654,000	-188,000	-302,000	1,873,000	1,458,000	473,000	263,000
Income before income taxes	-9,307,000	-2,764,000	3,156,000^r	4,324,000^r	2,427,000	-28,624,000	36,121,000	23,207,000	46,202,000	50,870,000
Income tax expense	672,000	6,064,000	6,595,000^r	2,124,000^r	-1,707,000	-4,642,000	8,928,000	4,485,000	14,386,000	18,323,000
Income from continuing operations	-9,979,000	-8,828,000	-3,439,000	2,200,000	·	·	·	·	·	·
Income from discontinued operations	-901,000	-47,557,000	-79,228,000	-17,059,000	·	·	·	·	·	·
Net income	-10,880,000	-56,385,000	-82,667,000	-14,859,000	4,134,000	-23,982,000	27,193,000	18,722,000	31,816,000	32,547,000
Earnings per share, basic	-0.76	-3.83	-5.64	-1.02	0.29	-1.69	1.93	1.30	2.18	2.22
Earnings per share, diluted	-0.76	-3.83	-5.64	-1.02	0.28	-1.69	1.89	1.27	2.11	2.15
Weighted average shares, basic	14,339,000	14,721,000	14,656,000	14,561,000	14,401,000	14,222,000^r	14,121,000	14,441,536^r	14,575,000	14,682,000
Weighted average shares, diluted	14,339,000	14,721,000	14,656,000	14,787,000^r	14,634,000	14,222,000^r	14,374,000	14,689,041^r	15,068,000	15,116,000

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:SalesRevenueNet

Cost of revenue what it cost to make or buy what it sold

us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations

Income from discontinued operations profit or loss from businesses it sold or closed

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton ANIK · research, not advice